Investigators reviewed 373 medical records of neonates diagnosed with hypoxic-ischemic encephalopathy after birth asphyxia at Jimma University Medical Center. They reported an overall mortality of 9.1%. Median event-free survival time was 30.6 days in the cohort. Short, early survival remained high: the probability at day 1 was 0.99 (95% CI: 0.99–1.00). Survival declined across the neonatal period; the Kaplan-Meier estimate fell to 0.75 (95% CI: 0.65–0.86) by day 20 and to 0.29 (95% CI: 0.15–0.59) by day 40. The study team observed a statistically significant difference in survival by disease stage (log-rank χ² = 45.4; p = 0.00), indicating that survival trajectories diverge with increasing HIE severity.
The cohort composition varied by severity. Stage I disease accounted for 121 neonates (32.4%); Stage II comprised 169 neonates (45.3%); and Stage III included 83 neonates (22.3%). Data extraction used a structured checklist, and analyses reflected routinely recorded clinical variables in the medical records. The abstract did not report additional stratified demographic details such as gestational age distributions, sex, or exact birthweight categories beyond the presence of macrosomia; those specifics were not provided in the source abstract.
The authors used Cox proportional hazards regression to identify variables independently associated with mortality. Stage II HIE was associated with an increased hazard of death (AHR reported in the abstract). Acute kidney injury carried a higher hazard as well. Low Apgar scores predicted mortality: an Apgar score ≤ 3 and scores of 4–6 were both associated with higher hazard ratios compared with neonates with better scores. Outborn status—neonates born outside the admitting facility—was associated with increased mortality, and neonatal sepsis also emerged as an independent predictor. The investigators declared statistical significance at p < 0.05. The abstract provided adjusted hazard ratios and 95% confidence intervals for these predictors; those point estimates and intervals are available in the source.
To evaluate contributors to worsening encephalopathy, the study team ran ordinal logistic regression across HIE stages. They found that outborn status was associated with higher odds of more severe HIE (AOR = 1.50; 95% CI: 1.00–2.26). Acute kidney injury increased the odds of greater severity (AOR = 1.93; 95% CI: 1.21–3.08). Macrosomia showed a substantial association with higher HIE stage (AOR = 2.54; 95% CI: 1.29–5.07). Hypoglycemia was also associated with increasing severity (AOR = 1.59; p = 0.01). Maternal gestational diabetes had a borderline association (AOR = 1.99; 95% CI: 0.97–4.10), as reported in the abstract. The source did not provide further mechanistic or temporal details linking these factors to severity beyond the reported associations.
The authors concluded that HIE remains a substantial contributor to neonatal mortality at JUMC and that survival falls sharply with more severe encephalopathy. They recommended strengthening referral systems and improving perinatal care. Early detection and prompt management of neonatal complications—specifically acute kidney injury, hypoglycemia, and sepsis—were identified as targets to reduce mortality and prevent progression of HIE. The abstract did not report long-term neurodevelopmental follow-up results or specific interventional protocols; those elements were not provided in the source.
Study design and reporting notes. The source describes a retrospective cohort using routinely collected medical-record data and lists the statistical methods used (Kaplan-Meier, log-rank, Cox regression, ordinal logistic regression) with significance set at p < 0.05. The abstract does not give detailed inclusion/exclusion criteria, gestational age breakdowns, specific management interventions provided during admission, or granular timing of events; those details were not reported in the abstract. Investigators obtained ethical clearance from the Institutional Review Board of Jimma University and received permission from relevant clinical leadership; informed consent was waived because the work was a retrospective record review.
Unanswered questions and gaps for clinical practice. The abstract documents clear associations but does not provide information on causality, time-to-intervention intervals, or standardized in-hospital management protocols that might modify outcomes. It also does not present long-term neurodevelopmental outcomes for survivors. These are unresolved clinical questions based on the data presented and could inform targeted quality-improvement or prospective research initiatives at the center.
Limitations and concrete next steps. The abstract reports single-center, retrospective analyses and recommends operational interventions already cited by the authors: strengthen referral pathways, enhance perinatal and delivery-room care, and prioritize early recognition and management of complications such as acute kidney injury, hypoglycemia, and neonatal sepsis to reduce mortality and limit progression of HIE.